SCHEMBL1434515

SCHEMBL1434515

ClC1=NN(Cl)NC(N2CCOCC2)=C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ GAA P10253 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ KMT2A Q03164 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ AR P10275 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ MAPK1 P28482 2/20 0.31
▸ TYMP P19971 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL912707 0.83 POLB (0.35) MAPTCYP1A2CYP2D6GAASMN1; SMN2
SCHEMBL8400813 0.77 POLB (0.36) POLB
SCHEMBL19027031 0.71 MAPT (0.35) MAPTCYP1A2CYP2D6GAASMN1; SMN2
SCHEMBL9483647 0.67 KDM4E (0.34) MAPTGAASMN1; SMN2KDM4ENPC1
SCHEMBL9445300 0.64 CYP1A2 (0.32) MAPTCYP1A2CYP2D6
SCHEMBL28091427 0.61 KMT2A (0.36) MAPTCYP1A2CYP2D6GAASMN1; SMN2
SCHEMBL3701153 0.58 LMNA (0.42) GAAKMT2AKDM4EJAK3POLB
SCHEMBL6173016 0.58 HPGD (0.32) MAPTCYP2D6SMN1; SMN2KMT2AKDM4E
SCHEMBL19027124 0.58 GAA (0.40) MAPTCYP1A2CYP2D6GAASMN1; SMN2
SCHEMBL7340553 0.57 GAA (0.37) MAPTGAASMN1; SMN2KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586507-B2 For stabilizing polyolefins, especially thermoplastic polyolefins, against the deleterious effects of oxidative, thermal and actinic radiation, also for stabilizing acid catalyzed and ambient cured coatings systems CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-01 — — US claimed
EP-1411084-B1 ANTIBACTERIAL COMPOSITION FOR MEDICAL TOOL ADEKA CORP (JP) 2011-03-30 — — EP disclosed
US-7279509-B2 Antibacterial composition for medical tool ADEKA CORPORATION (JP) 2007-10-09 — — US disclosed
US-20040166163-A1 Antibacterial composition for medical tool ADEKA CORPORATION (JP) 2004-08-26 — — US disclosed
EP-1411084-A1 ANTIBACTERIAL COMPOSITION FOR MEDICAL TOOL ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2004-04-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040166163-A1 Antibacterial composition for medical tool NLRP3, NLRP1, MRPL37 MAPT 2832/4885CYP1A2 3570/4885CYP2D6 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback